热门资讯> 正文
Bright Green与PharmAGRI Capital Partners合并，任命新首席执行官
2025-09-16 14:57
- Bright Green (OTC:BGXXQ) announced merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing sovereignty.
- Effective immediately, Lynn Stockwell has been appointed CEO and Chairwoman of PharmAGRI.
- The transaction consolidates BGXX’s DEA registrations, Board of Pharmacy licensure, audited financials, and Nasdaq history into PharmAGRI under a court-supervised restructuring plan filed in the District of New Mexico.
- The company intends to complete its IPO before year-end 2025, positioning PharmAGRI for full market access.
More on Bright Green
- Financial information for Bright Green
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
